Biotech Industry at Stake in Human Gene Patent Decision

An article discussing the Supreme Court's plan to rule on whether human genes can be patented featured commentary from Andrew Torrance, professor of law.

“There is a strong aversion to patents that cover any aspect of the human body,” said Andrew Torrance, who teaches patent and biodiversity law at the University of Kansas and is a visiting scholar at the Massachusetts Institute of Technology. “It’s a gut-level principle. We don’t like the thought of humans as property, and we think of patents as property.”

Subscribe to RSS - biotech